WallStreetZenWallStreetZen

NASDAQ: QDEL
Quidelortho Corp Stock

$42.17-0.81 (-1.88%)
Updated Apr 12, 2024
QDEL Price
$42.17
Fair Value Price
N/A
Market Cap
$2.82B
52 Week Low
$41.75
52 Week High
$95.02
P/E
-281.13x
P/B
0.56x
P/S
1.64x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.00B
Earnings
-$10.10M
Gross Margin
49.8%
Operating Margin
3.95%
Profit Margin
-0.3%
Debt to Equity
0.71
Operating Cash Flow
$280M
Beta
0.61
Next Earnings
May 3, 2024
Ex-Dividend
N/A
Next Dividend
N/A

QDEL Overview

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how QDEL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

QDEL is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
QDEL is good value based on its book value relative to its share price (0.56x), compared to the US Medical Devices industry average (3.74x)
P/B vs Industry Valuation
QDEL is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more QDEL due diligence checks available for Premium users.

Be the first to know about important QDEL news, forecast changes, insider trades & much more!

QDEL News

Valuation

QDEL fair value

Fair Value of QDEL stock based on Discounted Cash Flow (DCF)
Price
$42.17
Fair Value
$75.63
Undervalued by
44.24%
QDEL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

QDEL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-281.13x
Industry
29.43x
Market
42.64x

QDEL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.56x
Industry
3.74x
QDEL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

QDEL's financial health

Profit margin

Revenue
$742.6M
Net Income
$7.0M
Profit Margin
0.9%
QDEL's Earnings (EBIT) of $118.50M... subscribe to Premium to read more.
Interest Coverage Financials
QDEL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$8.6B
Liabilities
$3.6B
Debt to equity
0.71
QDEL's short-term assets ($1.31B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
QDEL's long-term liabilities ($2.72B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
QDEL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
QDEL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$80.4M
Investing
-$55.1M
Financing
-$57.8M
QDEL's operating cash flow ($280.20M)... subscribe to Premium to read more.
Debt Coverage Financials

QDEL vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
QDEL$2.82B-1.88%-281.13x0.56x
LIVN$2.86B-2.00%160.58x2.24x
TMDX$3.00B-2.27%-119.25x21.89x
PRCT$2.58B-4.89%-22.64x9.21x
IART$2.57B-1.06%38.59x1.62x

Quidelortho Stock FAQ

What is Quidelortho's quote symbol?

(NASDAQ: QDEL) Quidelortho trades on the NASDAQ under the ticker symbol QDEL. Quidelortho stock quotes can also be displayed as NASDAQ: QDEL.

If you're new to stock investing, here's how to buy Quidelortho stock.

What is the 52 week high and low for Quidelortho (NASDAQ: QDEL)?

(NASDAQ: QDEL) Quidelortho's 52-week high was $95.02, and its 52-week low was $41.75. It is currently -55.62% from its 52-week high and 1.01% from its 52-week low.

How much is Quidelortho stock worth today?

(NASDAQ: QDEL) Quidelortho currently has 66,849,490 outstanding shares. With Quidelortho stock trading at $42.17 per share, the total value of Quidelortho stock (market capitalization) is $2.82B.

Quidelortho stock was originally listed at a price of $3.63 in Dec 31, 1997. If you had invested in Quidelortho stock at $3.63, your return over the last 26 years would have been 1,063.31%, for an annualized return of 9.9% (not including any dividends or dividend reinvestments).

How much is Quidelortho's stock price per share?

(NASDAQ: QDEL) Quidelortho stock price per share is $42.17 today (as of Apr 12, 2024).

What is Quidelortho's Market Cap?

(NASDAQ: QDEL) Quidelortho's market cap is $2.82B, as of Apr 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Quidelortho's market cap is calculated by multiplying QDEL's current stock price of $42.17 by QDEL's total outstanding shares of 66,849,490.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.